Summer 2018  |  35 Coleen Glessner, SVP and chief quality officer, Alexion Pharmaceuticals, Inc. Cecile Guegan, VP finance global oncology and medicine development, Pfizer Inc. Jennifer Jackson, PhD, SVP, global regulatory affairs and quality assurance, Tesaro, Inc. Petra Jantzer, managing director, Accenture Tracey Keele, partner, risk consulting, KPMG LLP Andrea Kretzmann, strategy, Fingerpaint Marketing, Inc. Lauren Lewis, EVP, managing director, McCann Torre Lazur Anila Lingamneni, VP, renal R&D, Baxter healthcare, Baxter International Inc. Kellie Malloy, EVP, Syneos Health Nahrin Marino, deputy general counsel legal regulatory, Astellas Pharma US, Inc. Jymme McQuillan, executive director, operations, Quest Diagnostics Nikkia Miller-Blakes, Johnson & Johnson technology, VP— enterprise and portfolio, Johnson & Johnson Jan Price, director, women’s healthcare and neurology medical science liaison teams, Bayer Rosemary Rebuli, global head of trial management, Novartis Pharmaceuticals Corporation Dawn Rogers, SVP, human resources, Pfizer Inc. Robin Shapiro, global president, TBWA\WorldHealth Meg Smith, VP, clinical operations, quality and regulatory compliance, Stryker Corporation Cecilia Soriano, VP/GM diabetes care, BD Ponni Subbiah, chief medical officer, Indivior PLC Lisa Talbot, managing director, healthcare strategy and business development, Marina Maher Communications LLC Onelia Ann Vera, legal group VP, hematology, Shire Erica Yahr, EVP, executive strategy director, McCann Health NY Sherri Zapinski, VP, global procurement, Alcon, a Novartis Company Litao Zhang, PhD, VP, leads discovery and optimization, Bristol-Myers Squibb Company